People · Operator
Named in public records as an officer, director or promoter · active 2003–2011 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Applied Genetic Technologies Corp | — | Biotechnology | Series B | $42.9M | $340.5M | 2003 |
| Macrogenics Inc | — | Biotechnology | Series A | $12.0M | $434.4M | 2011 |
SCOTT KOENIG at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside SCOTT KOENIG on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arnold Oronsky | 2 | 10 |
| Garheng Kong | 1 | 16 |
| Ed Hurwitz | 1 | 9 |
| PAUL SEKHRI | 1 | 7 |
| Michael Steinmetz | 1 | 4 |
| Samuel B. Wu | 1 | 2 |
| Arnold B Oronsky | 1 | 1 |
| SAM B WU | 1 | 1 |
| NICHOLAS B MUZYCZKA | 1 | 1 |
| FRANK TOP | 1 | 1 |
| NICHOLAS MUZYCZKA | 1 | 1 |
| Ken Galbraith | 1 | 1 |
| James Karrels | 1 | 1 |
| Paulo Costa | 1 | 1 |
| Kent B Gossett | 1 | 1 |
| James B Rosen | 1 | 1 |
| Susan B Washer | 1 | 1 |
| Edward B Hurwitz | 1 | 1 |
| Scott B Koenig | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.